Inventor · disambiguated record
Johanne Kaplan
Also filed as: KAPLAN JOHANNE · KAPLAN JOHANNE M
17 granted patents·17 pending applications·278 citations·filing 1997–2025
93Inventor score
Files withEVELO BIOSCIENCES INC9UNIV BRITISH COLUMBIA9GENZYME CORP8SHEPHERD THERAPEUTICS INC3KAPLAN JOHANNE M2
Top patents by PatentIndex Score
34 records- 0197US9610307B2Probiotic compositions containing clostridiales for inhibiting inflammationEVELO BIOSCIENCES INC·Filed 2015·Granted Apr 4, 2017·129 cites·30 claims
- 0297US9603878B2Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host diseaseEVELO BIOSCIENCES INC·Filed 2015·Granted Mar 28, 2017·50 cites·29 claims
- 0393US11607432B2Probiotic compositions containing clostridiales for inhibiting inflammationEVELO BIOSCIENCES INC·Filed 2019·Granted Mar 21, 2023·4 cites·14 claims
- 0493US10980845B2Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiomeEVELO BIOSCIENCES INC·Filed 2015·Granted Apr 20, 2021·11 cites·30 claims
- 0591US10869903B2Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host diseaseEVELO BIOSCIENCES INC·Filed 2017·Granted Dec 22, 2020·7 cites·7 claims
- 0687US11612622B2Probiotic compositions containing clostridiales for inhibiting inflammationEVELO BIOSCIENCES INC·Filed 2018·Granted Mar 28, 2023·1 cites·9 claims
- 0785US6100086ATransgene expression systemsGENZYME CORP·Filed 1997·Granted Aug 8, 2000·55 cites·15 claims
- 0878US11672834B2Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiomeEVELO BIOSCIENCES INC·Filed 2021·Granted Jun 13, 2023·0 cites·20 claims
- 0971US7014848B1Enhanced anti-tumor immunityGENZYME CORP·Filed 2000·Granted Mar 21, 2006·2 cites·12 claims
- 1069US6358507B1Transgene expression systemsGENZYME CORP·Filed 1999·Granted Mar 19, 2002·18 cites·17 claims
- 1169US2025051428A1Antibodies to amyloid betaUNIV BRITISH COLUMBIA·Filed 2024·Application pending·0 cites
- 1266US12404321B2Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereofUNIV BRITISH COLUMBIA·Filed 2019·Granted Sep 2, 2025·0 cites·18 claims
- 1364US2025346655A1Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereofUNIV BRITISH COLUMBIA·Filed 2025·Application pending·0 cites
- 1464US2018169153A1Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft verses host diseaseEVELO BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 1563US2018015130A1Probiotic compositions containing clostridiales for inhibiting inflammationEVELO BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 1662US9617343B2Methods and compositions for treating lupusKAPLAN JOHANNE M·Filed 2010·Granted Apr 11, 2017·1 cites·17 claims
- 1762US2010183541A1Methods of Treating Autoimmune DiseasesGENZYME CORP·Filed 2008·Application pending·0 cites
- 1858US9744233B2Methods of treating autoimmune diseasesGENZYME CORP·Filed 2012·Granted Aug 29, 2017·0 cites·13 claims
- 1957US6485720B2Transgene expression systemsGENZYME CORP·Filed 2001·Granted Nov 26, 2002·0 cites·12 claims
- 2056US12071472B2Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomersUNIV BRITISH COLUMBIA·Filed 2017·Granted Aug 27, 2024·0 cites·19 claims
- 2153US2017326203A1Methods of Treating Autoimmune DiseasesGENZYME CORP·Filed 2017·Application pending·0 cites
- 2252US10933061B2Pyrvinium pamoate therapies and methods of useSHEPHERD THERAPEUTICS INC·Filed 2018·Granted Mar 2, 2021·0 cites·31 claims
- 2351US2010034782A1Methods of Using Anti-Thymocyte Globulin and Related AgentsNAJAFIAN NADER·Filed 2007·Application pending·0 cites
- 2451US2022218805A1Conformation-specific epitopes in tau, antibodies thereto and methods related thereofUNIV BRITISH COLUMBIA·Filed 2020·Application pending·0 cites
- 2550US2023141177A1Antibodies to misfolded amyloid betaUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 2649US2023174630A1Single chain antibodies and intrabodies to misfolded tdp-43 and methods of useUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 2749US2013344092A1Methods of Using Anti-Thymocyte Globulin and Related AgentsBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 2846US2021228564A1Pyrvinium pamoate therapies and methods of useSHEPHERD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2946US2025289877A1Antibodies to Amyloid BetaUNIV BRITISH COLUMBIA·Filed 2025·Application pending·0 cites
- 3045US2017369583A1Methods and compositions for treating lupusGENZYME CORP·Filed 2017·Application pending·0 cites
- 3139US12286469B2Humanized antibodies binding to amyloid-beta (A-beta)UNIV BRITISH COLUMBIA·Filed 2018·Granted Apr 29, 2025·0 cites·22 claims
- 3234US2019175560A1Mebendazole cancer therapies and methods of useSHEPHERD THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3332US2011280827A1Methods and compositions for treating hematological malignanciesHU YANPING·Filed 2010·Application pending·0 cites
- 3428US2012058082A1Methods and compositions for treatmentKAPLAN JOHANNE M·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johanne Kaplan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →